SREBF2 and hepatocellular carcinoma: Mechanistically, we proposed that maprotiline may restrain cholesterol biosynthesis to inhibit the growth and metastasis of HCC cells through the ERK-SREBP2 signaling pathway by interacting with CRABP1.